ALASKA: INBRE collaborates with COVID Variants Dashboard
Alaska INBRE is pleased to share the Alaska Coronavirus Variants Dashboard generated as a collaboration with the Alaska SARS-CoV2 Sequencing Consortium. The public can easily explore variants by economic region of Alaska, in vaccine breakthroughs, and over time.
Coronavirus variants have the potential to spread more rapidly, cause more severe disease, evade diagnostic detection, or reduce vaccine efficacy. With emergency use authorization (EUA) of monoclonal antibody treatments, which are targeted towards particular variants, this data can help guide what treatment to give patients by helping determine what variant patients are most likely infected with. Timely and accurate surveillance of SARS-CoV-2 variants is key to informing public health policy and thus efforts to control the pandemic in Alaska.
This dashboard was created as part of the Alaska SARS-CoV-2 Sequencing Consortium which is an partnership between the University of Alaska, Alaska State Virology Lab, Alaska Department of Health and Social Services, and other state agencies with the aim to increase genomic surveillance of variants of concern (VOC), variants of interest (VOI), and variants being monitored (VBM) in the state of Alaska.
This work is supported by Epidemiology and Laboratory Capacity for Prevention and Control of Emerging Infectious Diseases (ELC) from the Centers for Disease Control and Prevention and Alaska INBRE, an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health under grant number 2P20GM103395.